CUSIP: 576314108
Q3 2014 13F Holders as of 30 Sep 2014
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
23,699,435
-
Share change
-
+4,962,453
-
Total reported value
-
$13,209,000
-
Put/Call ratio
-
3.1%
-
Price per share
-
$0.56
-
Number of holders
-
29
-
Value change
-
+$2,726,678
-
Number of buys
-
12
-
Number of sells
-
10
Quarterly Holders Quick Answers
What is CUSIP 576314108?
CUSIP 576314108 identifies MSTX - MAST THERAPEUTICS INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q4 2014
-
Previous quarter:
Q2 2014
Recent filing periods for CUSIP 576314108:
Institutional Holders of MAST THERAPEUTICS INC - COM (MSTX) as of Q3 2014
As of 30 Sep 2014,
MAST THERAPEUTICS INC - COM (MSTX) was held by
29 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
23,699,435 shares.
The largest 10 holders included
FRANKLIN RESOURCES INC, BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, MPM ASSET MANAGEMENT LLC, DEUTSCHE BANK AG\, GRT CAPITAL PARTNERS LLC, GEODE CAPITAL MANAGEMENT, LLC, KCG Holdings, Inc., DIMENSIONAL FUND ADVISORS LP, and Ancora Advisors, LLC.
This page lists
29
institutional shareholders reporting positions in this security
for the Q3 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.